Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity

SIMPLE SUMMARY: Colorectal cancer (CRC) is the second cause of cancer death worldwide. Irinotecan is a drug widely used in CRC treatment. Unfortunately, colonic bacteria decompose the metabolite of irinotecan back to the active form of the drug resulting in severe side-effects of the treatment, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Palko-Łabuz, Anna, Maksymowicz, Jerzy, Sobieszczańska, Beata, Wikiera, Agnieszka, Skonieczna, Magdalena, Wesołowska, Olga, Środa-Pomianek, Kamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231545/
https://www.ncbi.nlm.nih.gov/pubmed/34204704
http://dx.doi.org/10.3390/cancers13122952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231545/
https://www.ncbi.nlm.nih.gov/pubmed/34204704
http://dx.doi.org/10.3390/cancers13122952

Ejemplares similares